Evidence map›Paper›PMID 41540977›Full record

ArticleRSC pharmaceutics2026

Effects of microparticle composition on colony morphology and viability of encapsulated therapeutic yeast for oral delivery.

Emma Etter, Alita F Miller, Timothy Little, Sri Sruthi Potluru, Srilekha Venkatraman, Juliane Nguyen

Abstract read
In one paragraph

Article in RSC pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Targeted and quantitatively modeled biologic delivery via dual-functional probiotic yeast in inflammatory bowel disease.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emma EtterJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA julianen@email.unc.edu.
Alita F MillerDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA.ORCID https://orcid.org/0009-0003-5360-7244
Timothy LittleDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA.
Sri Sruthi PotluruJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA julianen@email.unc.edu.
Srilekha VenkatramanJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA julianen@email.unc.edu.
Juliane NguyenJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill Chapel Hill NC 27599 USA julianen@email.unc.edu.ORCID https://orcid.org/0000-0002-8578-7396

Funding

Targeted Probiotic Yeast for Treating Inflammatory Bowel DiseasesR01DK140954 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Janelle C Arthur, Juliane Nguyen · 2025 to 2026
$1.6M
NIDDK NIH HHS R01 DK140954
6 · The paper itself

Abstract

Engineered live biotherapeutic products (LBPs) offer a promising avenue for targeted drug delivery, particularly within the gastrointestinal (GI) tract. Among microbial chassis,

Identifiers

PMID41540977
PMCPMC12801120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.